Covered recipient · General Payments record
STEVEN D PEINE
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$1,522.20
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $274.25 | 15 |
| Education | $15.96 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $142.13 | 8 |
| Biofrontera Inc. | $44.69 | 3 |
| LEO Pharma Inc. | $42.96 | 2 |
| Arcutis Biotherapeutics, Inc. | $24.55 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.92 | 1 |
| Regeneron Healthcare Solutions, Inc. | $15.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.61 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105227559 | CMS |
| ABBVIE INC. | $22.30 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105227563 | CMS |
| ABBVIE INC. | $12.74 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105227567 | CMS |
| ABBVIE INC. | $29.30 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105227571 | CMS |
| ABBVIE INC. | $22.45 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105227575 | CMS |
| ABBVIE INC. | $9.89 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105227579 | CMS |
| ABBVIE INC. | $21.11 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105227583 | CMS |
| ABBVIE INC. | $11.73 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105227587 | CMS |
| Arcutis Biotherapeutics, Inc. | $24.55 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121074975 | CMS |
| Biofrontera Inc. | $21.53 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091175287 | CMS |
| Biofrontera Inc. | $12.00 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107178434 | CMS |
| Biofrontera Inc. | $11.16 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108518520 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.92 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118038700 | CMS |
| LEO Pharma Inc. | $18.54 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152646135 | CMS |
| LEO Pharma Inc. | $24.42 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152646137 | CMS |
| Regeneron Healthcare Solutions, Inc. | $15.96 | 08/15/2024 | Education | Undisputed | 01/23/2026 | 1114135304 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.